Updated:
Abbott Laboratories US
Abbott Laboratories established its defined benefit pension plan to meet long-term employee obligations. The plan sits within the broader corporate structure...
Abbott Laboratories US
Abbott Laboratories established its defined benefit pension plan to meet long-term employee obligations. The plan sits within the broader corporate structure led by Robert B. Ford since his appointment as CEO. The plan allocates across public equities, fixed income, and private investments. Abbott Ventures has taken positions in HighT-Tech, Bigfoot Biomedical, SetPoint Medical, Neurogenetic Pharmaceuticals, and Exicure. Geographic exposure centers on the United States with additional activity in Europe through manufacturing assets in Ireland. External managers including Arrowstreet Capital, Baillie Gifford, Dodge & Cox, and Legal & General handle portions of the public portfolio. The plan reports $12.8 billion in assets. Abbott maintains the Abbott Fund, a separate philanthropic vehicle established in 1951 that directs grants toward health and science education globally. In February 2026 the firm attended the NYSTRS MWBE Investments and Professional Services Conference as an attendee. The pension plan maintains a direct relationship with the parent operating company through shared executive oversight and treasury functions. This architecture keeps investment decisions aligned with corporate cash flow and liability projections rather than external LP mandates.
General information
Firm type
Pension Fund
Year founded
1996
Location
Region
North America
Country
United States
City
Abbott Park
Principals
Robert B. Ford
Chairman and CEO
Philip P. Boudreau
Executive Vice President and CFO
Hubert L. Allen
Executive Vice President and General Counsel
Sector focus
Frequently asked questions
Who runs investment decisions at Abbott Laboratories US?
Philip P. Boudreau as CFO oversees financial management and pension assets with support from external consultants including Aon.
Does Abbott Laboratories US participate in fund commitments or only direct deals?
Abbott Ventures executes direct investments and limited partner commitments in private companies including HighT-Tech and SetPoint Medical.
Where does the underlying wealth come from?
The assets originate from the corporate defined benefit pension plan sponsored by Abbott Laboratories to cover employee retirement liabilities.
Does Abbott Laboratories US maintain philanthropic structures, and how are they separated?
The Abbott Fund operates as a separate foundation established in 1951 with an annual giving budget of approximately $20 million focused on health initiatives.
What investment stages does Abbott Laboratories US typically target?
Abbott Ventures targets operating businesses and early-stage companies in medical devices and biotechnology through its direct investment program.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on pension funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: